Grant: Engage Grants Program
Institut national de la recherche scientifique
$25,000.00
Polymer conjugation to the Feldan Shuttle to reduce blood protein adsorption and interaction with cell membranes
FY 2017-18
Summary
For a medication to be effective, it must be able to reach its target. One of the greatest challenges for manydrugs is that their targets lie inside cells. Indeed, cells are surrounded by a membrane that keeps manymolecules out - including drugs. Even the most powerful drug will be ineffective if it cannot reach its target.Feldan Therapeutics Inc. has developed a technology, termed the Feldan shuttle, which facilitates the transferof several types of drugs into cells. They now face a technological challenge, associated with the stability of theShuttle in blood, that they cannot resolve themselves. As such, Feldan Therapeutics Inc. has approached ProfMarc A Gauthier of the INRS to investigate structural alterations to the Shuttle and the influence of thesemodifications on: 1) the physical nature of complexes formed with therapeutic cargo, and 2) their interactionwith blood proteins.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
521307-2017
Name nom
Gauthier, Marc
Department département
Centre Énergie, Matériaux et Télécommunications (ÉMT) Varennes
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Polymer conjugation to the Feldan Shuttle to reduce blood protein adsorption and interaction with cell membranes
Keyword
NSERC
Application summary
For a medication to be effective, it must be able to reach its target. One of the greatest challenges for manydrugs is that their targets lie inside cells. Indeed, cells are surrounded by a membrane that keeps manymolecules out - including drugs. Even the most powerful drug will be ineffective if it cannot reach its target.Feldan Therapeutics Inc. has developed a technology, termed the Feldan shuttle, which facilitates the transferof several types of drugs into cells. They now face a technological challenge, associated with the stability of theShuttle in blood, that they cannot resolve themselves. As such, Feldan Therapeutics Inc. has approached ProfMarc A Gauthier of the INRS to investigate structural alterations to the Shuttle and the influence of thesemodifications on: 1) the physical nature of complexes formed with therapeutic cargo, and 2) their interactionwith blood proteins.